Which are the causes of Opsoclonus myoclonus syndrome?

TL;DR: Opsoclonus myoclonus syndrome (OMS) is a rare, immune-mediated neurological disorder primarily triggered by an abnormal immune response to an underlying tumor (paraneoplastic) or a viral infection. While the exact etiology is still under investigation, it is widely understood that the body’s immune system mistakenly attacks healthy brain cells in the cerebellum, leading to the characteristic "dancing eyes" and jerky muscle movements.

What causes Opsoclonus myoclonus syndrome?

The primary driver of Opsoclonus myoclonus syndrome is an autoimmune mechanism, where the body’s defense system—specifically B-cells and T-cells—crosses the blood-brain barrier and begins to attack neurons in the cerebellum, the part of the brain responsible for balance and coordination. In pediatric cases, Opsoclonus myoclonus syndrome is most frequently a paraneoplastic condition, meaning it is a remote effect of a neuroblastoma, a type of tumor arising from nerve tissue. In adults, the syndrome is more often associated with other malignancies (such as breast or lung cancer) or follows a viral infection. Essentially, the immune system is "tricked" into fighting a tumor or virus, but the antibodies it creates also bind to healthy brain tissue, causing the chaotic motor symptoms seen in Opsoclonus myoclonus syndrome.

Is Opsoclonus myoclonus syndrome a genetic disease?

Opsoclonus myoclonus syndrome is not considered a hereditary or genetic disease. It is not caused by a single mutated gene passed down from parents to children. While researchers are looking into whether certain genetic predispositions might make an individual’s immune system more prone to developing this type of post-viral or paraneoplastic autoimmunity, there is no known genetic marker for the condition. Current research focuses on the molecular mimicry hypothesis, where the body fails to distinguish between the antigens of a pathogen or tumor and the proteins found on cerebellar neurons.

What are the identified triggers for this condition?

The triggers for Opsoclonus myoclonus syndrome can vary significantly between pediatric and adult patients. Understanding these triggers is vital for diagnosis and treatment. The following list highlights the most common associations identified in clinical literature:

• Neuroblastoma: Found in approximately 50% of pediatric patients with Opsoclonus myoclonus syndrome.


• Viral Infections: Conditions like Epstein-Barr virus, enteroviruses, or West Nile virus have been identified as preceding triggers.


• Paraneoplastic syndromes: In adults, occult cancers (most commonly lung, breast, or ovarian) may trigger the immune response.


• Idiopathic cases: In many instances, no definitive trigger is found despite extensive testing, which researchers categorize as idiopathic.

How does research aim to better understand the etiology?

Because the cause is not fully understood, current research is intensely focused on identifying the specific autoantibodies involved in Opsoclonus myoclonus syndrome. By mapping the exact proteins that these antibodies target, scientists hope to develop more targeted immunotherapies that stop the attack on the brain without suppressing the entire immune system. Within the DiseaseMaps community, 7 people with Opsoclonus myoclonus syndrome have shared their experiences, providing valuable anecdotal data that helps researchers understand the diverse ways this condition presents and evolves over time.

Next steps

• Consult a pediatric or adult neurologist who specializes in neuro-immunology.


• Undergo comprehensive imaging (such as an MRI or MIBG scan) to rule out underlying tumors.


• Consider joining a patient support group or the DiseaseMaps.org community to connect with others sharing similar clinical journeys.


• Ask your physician about the latest clinical trials investigating B-cell depletion therapies.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of a qualified healthcare professional regarding any medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD) - Opsoclonus Myoclonus Syndrome.


• Orphanet: The portal for rare diseases and orphan drugs (ORPHA: 666).


• OMIM (Online Mendelian Inheritance in Man) - Clinical summaries on autoimmune neurological disorders.


• National Institute of Neurological Disorders and Stroke (NINDS) - Rare Disease Information.